Nimesulide in the treatment of patients intolerant of aspirin and other NSAIDs

Drug Safety

Volumn 14, Issue 2, 1996, Pages 94-103

  Senna, Gian E ^a   Passalacqua, Giovanni ^b   Andri, Giovanni ^a   Dama, Anna R ^a   Albano, Monica ^b   Fregonese, Laura ^b   Andri, Luigi ^a,c  

^a Verona General Hospital   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARYLPROPIONIC ACID DERIVATIVE; CORTICOSTEROID; IBUPROFEN; IMMUNOGLOBULIN E ANTIBODY; INDOMETACIN; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PHENYLBUTAZONE; PIROXICAM; PROSTAGLANDIN SYNTHASE; PYRAZOLONE; TERFENADINE;

ALLERGIC RHINITIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHOSPASM; CLINICAL FEATURE; CLINICAL TRIAL; DROWSINESS; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG SELECTIVITY; DRUG STRUCTURE; ERYTHEMA; GASTROINTESTINAL DISEASE; HUMAN; HYPOTENSION; INFLAMMATORY DISEASE; INHALATIONAL DRUG ADMINISTRATION; NEPHROTOXICITY; NONHUMAN; NOSE POLYP; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY ARREST; REVIEW; SHOCK; STEVENS JOHNSON SYNDROME; TACHYCARDIA; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VERTIGO;

EID: 0030061018     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199614020-00004     Document Type: Review

References (73)

1. Faich GA. Special Report. Adverse drug reaction monitoring. N Engl J Med 1986; 314: 1589-92
2. Kallos P, Schlumberger HD. Pseudo-allergic reactions. Int Arch Allergy Appl Immunol 1987; 82: 1-3
3. Settipane GA. Aspirin and allergic diseases. Am J Med 1983; 74: 102-10
4. Delaney JC. Asthma, nasal polyps, aspirin idiosyncrasy. Clin Allergy 1975; 5: 234-8
5. Phills JA, Perelmutter L. IgE-mediated and IgE-non mediated allergic type reactions to aspirin. Acta Allergol 1974; 29: 474-90
6. Krilis S, Gregson RP, Basten A, et al. Investigation of the possible involvement of IgE anti-salicyloil antibodies in patients with urticaria. Int Arch Allergy Appl Immunol 1981; 64: 293-301
7. Bundgaard H, De Weck AL. The role of amino-reactive impurities in acetylsalicylic acid. Int Arch Allergy Appl Immunol 1975; 49: 119-24
8. Adams GK, Lichtenstein LM. Indomethacin enhances response of human bronchus to antigen. Am Rev Resp Dis 1985; 131: 8-10
9. Marone G, Kagey-Sobotka A, Lichtenstein LM. Effects of arachidonic acid and metabolite on antigen-induced histamine release from human basophils in vitro. J Immunol 1979; 123: 1669-77
10. Marone G, Casolaro V, Cirillo L, et al. Pathophysiology of human basophils and mast cells in allergic disorders. Clin Immunol Immunopathol 1989; 50: 524-40
11. Okazaki T, Ilea VS, Rosario NA, et al. Regulatory role of prostaglandin E in allergic histamine release with observation on the responsiveness of basophil leucocytes and the effect of acetylsalicylic acid. J Allergy Clin Immunol 1977; 60: 360-6
12. Stevenson DD, Lewis RA. Proposed mechanisms of aspirin sensitivity reactions. J Allergy Clin Immunol 1987; 80: 788-90
13. Szczeklik A. Aspirin-induced asthma: pathogenesis and clinical presentation. Allergy Proc 1992; 13: 163-74
14. 4 concentrations increase after aspirin challenge in aspirin sensitive asthmatic subjects. Am Rev Resp Dis 1991; 143: 1025-9
15. 4 in the urine and bronchial provocation with lysine-aspirin results in further release. Am Rev Resp Dis 1991; 142: A599
16. 4 in subjects with aspirin-sensitive asthma. Am Rev Resp Dis 1989; 140: 148-53
17. Christie PE, Smith CM, Lee TH. The potent and selective sulfidropeptide leukotriene antagonist, SK & F 104353 inhibits aspirin-induced asthma. Am Rev Resp Dis 1991; 144: 957-8
18. 2 synthesis in aspirin-induced asthma. J Allergy Clin Immunol 1987; 80: 839-43
19. Senna GE, Andri G, Dama AR, et al. Tolerability of imidazole salicylate in aspirin-sensitive patients. Allergy Proc 1995; 16: 251-4
20. Ferreri NR, Howland WC, Stevenson DD, et al. Release of leukotrienes, prostaglandins and histamine into nasal secretions of aspirin-sensitive asthmatics during reactions to aspirin. Am Rev Resp Dis 1988; 137: 847-54
21. Ortolani C, Mirone C, Fontana A, et al. Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients. Ann Allergy 1987; 59: 106-12
22. Szczeklik A. Aspirin-induced asthma: new insights into pathogenesis and clinical presentation of drug intolerance. Int Arch Allergy Appl Immunol 1989; 90: 70-5
23. Memorandum SIAIC. Diagnostica di allergia di farmaci. Folia Allergol Immunol Clin 1989; 36: 437-65
24. McDonald JR, Mathison DA, Stevenson DD. Aspirin intolerance in asthma: detection by oral challenge. J Allergy Clin Immunol 1972; 50: 198-207
25. Bianco S, Robuschi M, Petrigni G. Aspirin sensitivity in asthmatics [letter]. BMJ 1981; 282: 146
26. Phillips GS, Foord R, Holgate ST. Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin sensitive patients: its repeatability, absence of late phase reaction and the role of histamine. J Allergy Clin Immunol 1989; 84: 232-41
27. Shapowal AG, Schmitz-Schumann M, Szczeklik A, et al. Lysine-aspirin nasal provocation and anterior rhinomanometry for the diagnosis of aspirin sensitive asthma. Atmenwoechenschrift Lungenkrankheit 1990; 16: 1-5
28. Patriarca G, Nucera E, Di Rienzo V, et al. Nasal provocation test with lysine acetylsalicylate in aspirin sensitive patients. Ann Allergy 1991; 67: 60-2
29. Pawlowicz A, Williams WR, Davies BH. Inhalation and nasal challenge in the diagnosis of aspirin-induced asthma. Allergy 1991; 46: 405-9
30. Bennett A, Berti F, Ferreira HS, editors. Nimesulide: a multi-factorial therapeutical approach to inflammatory diseases? Drugs 1993; 46 Suppl. 1: 1-283
31. Ward A, Brodgen RN. Nimesulide: a preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states. Drugs 1988; 36: 732-53
32. Vane JR. Inhibition of prostaglandin synthesis as mechanism of action for aspirin-like drugs. Nature New Biol 1971; 1: 462
33. Rufer C, Schillinger E, Bottcher I, et al. Non steroidal antiinflammatories XII. Mode of action of antiinflammatory methane sulfonanilides. Bioch Pharmacol 1982; 31: 3591-6
34. Cipollini F, Mecozzi V, Altilia F. Endoscopic assessment of the effects of nimesulide on the gastric mucosa: comparison with indomethacin. Curr Ther Res 1989; 45: 1042-8
35. Tavares IA, Bishai PM, Bennet A. Activity of nimesulide on constitutive and inducible cylooxygenase. Arzneimittel Forschung 1995; 45: 1093-5
36. Vago T, Bevilacqua M, Norbiato G. Effect of nimesulide action time dependence on selectivity towards prostaglandin G/H synthetase/cyclooxygenase activity. Arzneimittel Forschung 1995; 45: 1096-8
37. Capsoni F, Venegone E, Minozio F, et al. Inhibition of neutrophil metabolism by nimesulide. Agents Actions 1987; 21: 121-9
38. Nielson C, Vestal RE, Sturm RJ, et al. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leucocyte respiratory burst. J Allergy Clin Immunol 1990; 86: 801-8
39. Bevilacqua R, Norbiato G, Baldi G, et al. Activation of protein kinase C by respiratory burst stimulants desensitizes beta 2 adrenoreceptors on human neutrophils: antagonism by drugs affecting protein kinase C. Drug Invest 1991; 3: 54-65
40. Nicholson CD, Challis RAJ, Shahid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Tips 1991; 12: 19-27
41. Rossoni G, Berti F, Buschi A, et al. New data concerning the antianaphylactic and antihistaminic activity of nimesulide. Drugs 1993; 46 Suppl. 1: 22-8
42. Berti F, Rossoni G, Buschi A, et al. Antianaphylactic and antihistaminic activity of the non-steroidal antiinflammatory compound nimesulide in guinea-pig. Arzneimittel Forschung 1990; 40: 1011-6
43. Berti F, Rossoni G, Robuschi M, et al. Protective effect of furosemide combined with NSAIDs administered by inhalation route on guinea pigs anaphylaxis model. Arzneim Forsch Drug Res 1995; 45: 1098-102
44. +) cells by nimesulide. Agents Actions 1992; Special Conference Issue: 1-4
45. Casolaro V, Meliota S, Marino O, et al. Nimesulide, a sulfonanilide non steroidal antiinflammatory drug, inhibits mediator release from human basophils and mast cells. J Pharmacol Exp Ther 1993; 267: 1375-85
46. Senna GE, Betteli C, Givanni S, et al. Antihistaminic activity of nimesulide, a non steroidal antiinflammatory drug [abstract]. J Allergy Clin Immunol 1993; 91: 201
47. Astarita C, Franzese A, Sproviero S, et al. Epidemiologia delle reazioni avverse ai farmaci antiinfiammatori non steroidei. La nimesulide è tollerata dai pazienti con reazioni avverse ai FANS e modula nell'uomo la risposta cutanea all'istamina ed alla codeina. Recenti Prog Med 1992; 83: 567-71
48. Atkins PC, Zweiman B, Littman B, et al. Products of arachidonic acid metabolism of cyclooxygenase inhibition on ongoing cutaneous allergic reactions in human beings. J Allergy Clin Immunol 1995; 95: 742-7
49. Verhoeven AJ, Tool ATJ, Kuijpers TW, et al. Nimesulide inhibits platelet activating factor synthesis in activated human neutrophils. Drugs 1993; 46 Suppl. 1: 52-8
50. Dapino P, Ottonello L, Dallegri F. The anti-inflammatory drug nimesulide inhibits neutrophil adherence and migration across monolayers of cytokine-activated endothelial cells. Respiration 1994; 61: 336-41
51. Canonica GW, Ciprandi G, Bagnasco L, et al. Adhesion molecules of the allergic inflammation: recent insight in their functional role. Allergy 1994; 49: 135-41
52. Canonica GW, Ciprandi G, Pesce GP, et al. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol 1995; 107: 99-102
53. Muratore L, Ferranini A, Toraldo MD, et al. Studio controllato sulla tollerabilità della nimesulide in pazienti con manifestazioni cutanee da intolleranza ad ASA e FANS. G Ital Allergol Immunol Clin 1992; 2: 157-62
54. Ispano M, Fontana A, Scibilia J, et al. Oral challenge with alternative non steroidal antiinflammatory drugs and paracetamol in patients intolerant to these agents. Drugs 1993; 46 Suppl. 1: 253-6
55. Andri L, Senna GE, Andri G, et al. Impiego della nimesulide in soggetti con intolleranza agli antiinfiammatori non steroidei. Folia Allergol Immunol Clin 1990; 37: 93-7
56. Andri L, Senna GE, Betteli C, et al. Tolerability of nimesulide in aspirin sensitive patients. Ann Allergy 1994; 72: 29-32
57. Passalacqua G, Albano M, Ruffoni S, et al. Safety of nimesulide as alternative drug in patients with adverse drug reactions. J Allergy Clin Immunol 1995; 95: 288
58. Robuschi M, Refini M, Sturman M, et al. La nimesulide non induce asma in pazienti asmatici FANS intolleranti. Proceedings of the International Symposium on Advances in Pneumology and Cardiology; 1987 May 27-28; Parma. Bologna: Monduzzi Publish., 1987: 431-5
59. Bianco S, Robuschi M, Petrigni G, et al. Efficacy and tolerabilily of nimesulide in asthmatic patients intolerant to aspirin. Drugs 1993; 46 Suppl. 1: 115-20
60. Senna GE, Andri G, Betteli C, et al. Tollerabilità della nimesulide nell'asma da aspirina e da antiinfiammatori non steroidei. Riassunti XXI Congresso SIAIC. 1994 Nov 9-12; Milan, 288
61. Bilancia R, Ferranini A, Chianese R, et al. Nimesulide tolerance in ASA-induced asthma. In: Basomba A, Sastre J, editors. Proceedings of the XVI European Congress of Allergology and Clinical Immunology; 1995 Jun 25-30; Madrid. Bologna: Monduzzi Publish., 1995: 559-62
62. Hargreave FE, Ramsdale EH, Kirby JC, et al. Asthma and the role of inflammation. Eur Resp J Dis 1986; 69 Suppl. 147: 16-21
63. Durham SR, Carroll M, Walsh GM, et al. Leukocyte activation in allergen-induced late-phase asthmatic reaction. N Engl J Med 1984; 311: 1398-402
64. De Monchy JGR, Kauffman HF, Venge P, et al. Bronchoalveolar eosinophilia during allergen-induced late-phase asthmatic reaction. Am Rev Resp Dis 1985; 131: 3773-6
65. Fabbri LM, Boschetto P, Zocca E, et al. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am Rev Resp Dis 1987; 136: 36-42
66. Durham SR, Kay AB. Eosinophils, bronchial hyperreactivity and late phase asthmatic reaction. Clin Allergy 1985; 16: 411-8
67. Fairfax AJ. Inhibition of the late asthmatic response to house dust mite by non-steroidal anti-inflammatory drugs. Prostaglandins Leukot Med 1982; 8: 239-48
68. Joubert JR, Shepard E, Mouton W, et al. Non-steroidal anti-inflammatory drugs in asthma: dangerous or useful therapy? Allergy 1985; 40: 202-7
69. Bianco S, Pieroni MG, Refini RM, et al. Could NSAIDs have a role as antiasthmatic agents? Drugs 1994; 48 (1): 9-15
70. Nasser SMS, Lee TH. Aspirin-induced early and late asthmatic response. Clin Exp Allergy 1995; 25: 1-3
71. De Lucia F, Bonavia M, Crimi E, et al. Antiinflammatory-antioxidant treatment with a methane sulfonanilide in allergen-induced asthma. Ann Allergy 1991; 66: 29-32
72. Andri L, Senna GE, Betteli C, et al. Combined treatment of allergic rhinitis with terfenadine and nimesulide, a non steroidal antiinflammatory drug. Allergie Immunol 1992; 24: 313-9
73. Andri L, Senna GE, Givanni S, et al. Use of nimesulide, a non steroidal anti-inflammatory compound (NSAID) in allergic rhinitis [abstract]. Allergy 1992; 47: 243